ClinicalTrials.Veeva

Menu

Surgicel® (Fibrillar) in Non-variceal UGI Bleeding

S

Soon Chun Hyang University

Status

Unknown

Conditions

Non-variceal Upper Gastrointestinal Bleeding

Treatments

Drug: Surgicel

Study type

Interventional

Funder types

Other

Identifiers

NCT02054260
SCHBC_IRB_2013-40

Details and patient eligibility

About

The aim of this study is to assess of effect of Surgicel® (Fibrillar) for preventing delayed bleeding after endoscopic hemostasis in non-variceal upper gastrointestinal bleeding

Sex

All

Ages

20 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with non variceal upper gastrointestinal bleeding proven by esophagogastroduodenoscopy
  • Patients with active bleeding (Forrest classification Ia or Ib or IIa)

Exclusion criteria

  • Patients with upper gastrointestinal tract malignancy
  • Patients with acute severe illness
  • Coagulopathy: liver cirrhosis, thrombocytopenia
  • Pregnant women

Trial design

0 participants in 1 patient group

Surgicel add therapy
Experimental group
Treatment:
Drug: Surgicel

Trial contacts and locations

1

Loading...

Central trial contact

Su Jin Hong, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems